Stock Events

Stock Events

Aclaris Therapeutics (8AT.F) Q4 2024 Earnings

6NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.27

-0.18

-0.09

-0.01

Details

Expected EPS

-0.005243909220000001

Actual EPS

-0.1009503

Surprise EPS

-0.1

Surprise Percent

+1,825.1%

Description

Aclaris Therapeutics (8AT.F) has reported earnings of -0.1009503 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.